These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 4402312)

  • 1. Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.
    Winkelstein JA; Shin HS; Wood WB
    J Immunol; 1972 Jun; 108(6):1681-9. PubMed ID: 4402312
    [No Abstract]   [Full Text] [Related]  

  • 2. Heat labile opsonin system to pneumococcus.
    Shin HS; Smith MR; Winkelstein J; Nicholson A
    Birth Defects Orig Artic Ser; 1975; 11(1):563-6. PubMed ID: 238689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation.
    Jasin HE
    J Immunol; 1972 Jul; 109(1):26-31. PubMed ID: 4624675
    [No Abstract]   [Full Text] [Related]  

  • 4. An abnormality of the alternate pathway of complement activation in sickle-cell disease.
    Johnston RB; Newman SL; Struth AG
    N Engl J Med; 1973 Apr; 288(16):803-8. PubMed ID: 4144343
    [No Abstract]   [Full Text] [Related]  

  • 5. Bactericidal and opsonic properties of C4-deficient guinea pig serum.
    Root RK; Ellman L; Frank MM
    J Immunol; 1972 Sep; 109(3):477-86. PubMed ID: 4403402
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of chemotactic activity by guinea pig immunoglobulins following activation of the C3 complement shunt pathway.
    Sandberg AL; Snyderman R; Frank MM; Osler AG
    J Immunol; 1972 May; 108(5):1227-31. PubMed ID: 5029138
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoglobulins as aspecific opsonins. 3. The opsonizing power of fragments of polyclonal and monoclonal immunoglobulin G.
    Van Oss CJ; Woeppel MS; Marquart SE
    J Reticuloendothel Soc; 1973 Mar; 13(3):221-30. PubMed ID: 4196701
    [No Abstract]   [Full Text] [Related]  

  • 8. Opsonization of pneumococci. I. Heat-labile serum activity other than complement is required for killing by human polymorphonuclear leukocytes.
    Guckian JC; Christensen GD; Schweinle JE; Fine DP
    J Immunol; 1981 Oct; 127(4):1659-65. PubMed ID: 7276577
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.
    Winkelstein JA; Abramovitz AS; Tomasz A
    J Immunol; 1980 May; 124(5):2502-6. PubMed ID: 7365262
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural immunity to bacterial infections: the relation of complement to heat-labile opsonins.
    Smith MR; Shin HS; Wood WB
    Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1151-6. PubMed ID: 4390986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulins as aspecific opsonins. II. The influence of specific and aspecific immunoglobulins on the in vitro phagocytosis of noncapsulated, capsulated, and decapsulated bacteria by human neutrophils.
    Stinson MW; Van Oss CJ
    J Reticuloendothel Soc; 1971 May; 9(5):503-12. PubMed ID: 4104066
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of immunoglobulin in the interaction of pneumococci and the properdin pathway: evidence for its specificity and lack of requirement for the Fc portion of the molecule.
    Winkelstein JA; Shin HS
    J Immunol; 1974 May; 112(5):1635-42. PubMed ID: 4150446
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet injury due to activation of the alternate complement pathway.
    Siraganian RP; Sandberg AL; Alexander A; Osler AG
    J Immunol; 1973 Feb; 110(2):490-7. PubMed ID: 4119252
    [No Abstract]   [Full Text] [Related]  

  • 14. Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5.
    Shin HS; Smith MR; Wood WB
    J Exp Med; 1969 Dec; 130(6):1229-41. PubMed ID: 4390900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonic activity in human serum deficient in C2.
    Johnson FR; Agnello V; Williams RC
    J Immunol; 1972 Jul; 109(1):141-5. PubMed ID: 4402482
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of easily released substances (ERS) from bacteria into physiologic solutions in natural immunity. IV. The action of ERS from E. coli O 55 and O 111 on opsonins for Staphylococcus aureus in guinea pig sera.
    Grzybek-Hryncewicz K; Zielska U
    Arch Immunol Ther Exp (Warsz); 1974; 22(5):571-4. PubMed ID: 4614755
    [No Abstract]   [Full Text] [Related]  

  • 17. Participation of nonspecific factors in the destruction of type M12 streptococci in vitro. II. Indispensability of human complement and role of other factors in the bactericidal test.
    Kahlich R
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(2):172-83. PubMed ID: 5463710
    [No Abstract]   [Full Text] [Related]  

  • 18. Heat labile opsonins to pneumococcus. I. Participation of complement.
    Smith MR; Wood WB
    J Exp Med; 1969 Dec; 130(6):1209-27. PubMed ID: 4390899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of complement in human immediate hypersensitivity: evidence against involvement of the alternate pathway of complement activation.
    Grant JA; Lichtenstein LM
    J Immunol; 1973 Sep; 111(3):733-42. PubMed ID: 4126288
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased susceptibility to infection in sickle cell disease: defects of opsonization and of splenic function.
    Johnston RB; Newman SL; Struth AG
    Birth Defects Orig Artic Ser; 1975; 11(1):322-7. PubMed ID: 238677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.